Statistical tool could explain gene study variations

While scientists are using the human genome to associate certain genes with disease, Dr. Hongyan Xu wants to ensure they are accounting for natural variations in those genes.

"These differences can create some challenges in analyzing data," says Dr. Xu, biostatistician in the Medical College of Georgia School of Graduate Studies. "There is always some difference in ethnic backgrounds across a study population."

For instance, a study looking at a population of blacks from Augusta and blacks from Chicago wouldn't necessarily take into account the difference in subpopulations, he says.

"Some groups of blacks could have different degrees of ancestry from different African groups," he says. "Some populations of blacks have different skin tones, which indicate a difference in genetic makeup. That isn't always taken into account."

Scientists use genome-wide association studies to compare the genes of people with health conditions to the genes of healthy people, thereby better understanding basic biological processes that affect health and possibly how to better diagnose and treat disease.

Some studies account for differences by using control groups who self-report similar ethnicities. But there can be wide variations because people are not always completely aware of their ancestry, Dr. Xu says.

A computer-based statistical tool could be the answer, he says.

Dr. Xu and colleagues will start by examining an existing database from an ongoing association study of stroke risk in black children. That study, conducted by Dr. Abdullah Kutlar, hematologist/oncologist and director of the MCG Sickle Cell Center, aims to understand the genetics of stroke risk in children with sickle cell disease. With funding from the National Institutes of Health, Dr. Xu and his team will take a closer look at children already identified as high-risk because of high blood flow velocity in the brain, as measured by transcranial Doppler tests.

Previous MCG research identified high-velocity blood flow as a risk factor for stroke and regular blood transfusions as a way to reduce that risk.

"While Dr. Kutlar is looking for the underlying genetic reasons for the higher stroke risks in this sample of patients, we will be looking for ways to identify the subpopulations in that sample," Dr. Xu says. "If population structure isn't taken into account, it could affect the validity of study results."

Researchers will use a statistical approach known as coalescent theory, which traces coding sequences of genes in a population sample to a single ancestral copy of a gene. That gene would theoretically be copied in the genetics of every member of an identical population.

For instance, two people with almost identical sets of chromosomes could differ in a very small way – by one structural unit that binds their DNA. By tracing it back, researchers would reach a point where the "copied" gene would not be present. That would indicate the point where two lineages joined, Dr. Xu says.

Genetic differences among the two populations could then be tagged, subcategorized and accounted for in study results, he says.

"With the coalescent theory, we focus on the samples rather than the whole population," Dr. Xu says. "That way, we can generate samples with various levels of population structure with great efficiency using computers, which are important for large-scale genome-wide studies. Understanding the genetic basis for disease is key to prevention, diagnosis and effective treatment. Developing a method that accounts for variations in the genetics of people who are similar but distinct is crucial to better understanding the genetics of health."

Source: Medical College of Georgia

Related stories:

Large reservoir of mitochondrial DNA mutations identified in humans
Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. Clinical analysis of blood samples from almost 3,000 infants born in north Cumbria, England, showed that at least 1 in 200 individuals in the general public harbor mitochondrial DNA mutations that may lead to disease.
Study helps pinpoint genetic variations in European Americans
An international team of researchers has identified just 200 positions within the curves of the DNA helix that they believe capture much of the genetic diversity in European Americans, a population with one of the most diverse and complex historic origins on Earth. Their findings narrow the search for the elusive ancestral clues known as single nucleotide polymorphisms, or SNPs, that cause disease and account for the minute variations in the European American population.
Alaskan Eskimos' high rates of artery plaque could be from high smoking
Alaskan Eskimos' significantly higher rates of fatty artery plaque than the general U.S. population may be due to unhealthy lifestyle habits, researchers report in Stroke: Journal of the American Heart Association.
Mayo Clinic spearheads research to discover unsuspected gene for atrial fibrillation
Mayo Clinic researchers have found a gene mutation linked to one family's hereditary form of atrial fibrillation. Researchers hope this discovery will lead to better understanding of the disease and, eventually, better ways to predict, prevent and treat the heart rhythm problem.
Rare genetic mutations protect against hypertension
Howard Hughes Medical Institute (HHMI) researchers have found that rare mutations in three genes contribute to blood pressure variation in the general population.
Study verifies that cholesterol-associated gene variants can predict cardiovascular events
A study appearing in this week’s New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients’ cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death. Led by researchers from the Massachusetts General Hospital Cardiology Division, the study’s findings are a first step towards the ability to identify individuals who might benefit from earlier use of cholesterol-lowering medications and other measures to combat elevated risk.
Common blood pressure drug reduces progressive muscle degeneration in mice
Scientists supported in part by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Institute of Neurological Disorders and Stroke (NINDS) have found that that the commonly prescribed blood pressure medication losartan improves muscle regeneration and repair in a mouse model of Duchenne muscular dystrophy (DMD), a devastating disease characterized by rapid progression of muscle degeneration in boys and young men.
Researchers first to map gene that regulates adult stem cell growth
A new discovery in stem cell research may mean big things for cancer patients in the future. Gary Van Zant, Ph.D., and a research team at the University of Kentucky published their findings today in Nature Genetics.

News discussion:

General Science news